Bonnie Ky, MD
Enriched profileFounders Professor of Cardio-Oncology · University of Pennsylvania
Bonnie Ky is Founders Professor of Cardio-Oncology at University of Pennsylvania. OpenAlex indexes 470 publications with 27,426 citations (h-index 73); ClinicalTrials.gov lists 12 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Bonnie Ky, MD, is Founders Professor of Cardio-Oncology at University of Pennsylvania (Perelman School of Medicine). The public record shows 470 publications with 27,426 citations (h-index 73), centered on Chemotherapy-induced cardiotoxicity and mitigation, Cardiovascular Function and Risk Factors, Cardiac Imaging and Diagnostics. It also documents an investigator role on 12 registered clinical trials, industry payments reported by 4 companies, 11 NIH-funded awards (2010–2025).
- Most recent indexed publication: 2026 · Hypertension (Dallas, Tex.
- Top research focus: Chemotherapy-induced cardiotoxicity and mitigation
- 12 registered trials on ClinicalTrials.gov
- Open Payments reporting from 4 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 17 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 189.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 12 registered studies on ClinicalTrials.gov. The most recent:
- Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer
Sponsor: Abramson Cancer Center at Penn Medicine
- Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer
Sponsor: Abramson Cancer Center at Penn Medicine
- Pilot Study of an NTproBNP Guided Strategy of Cardioprotection
Sponsor: Abramson Cancer Center at Penn Medicine
Industry payments
Updated 27 Aug 2026
4 companies reported payments to CMS in program years 2021–2023. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20231 payment
- E.R. Squibb & Sons, L.L.C.Program year20221 payment
- Roche Diagnostics CorporationProgram year20221 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
82.1%Statin22.5%Atorvastatin Calcium57%Rosuvastatin Calcium43%Part D≥36 patientsBeta blocker17%Metoprolol Succinate56%Carvedilol44%Part D≥25 patientsMetabolism & gastrointestinal
15.6%SGLT2 inhibitor15.6%Farxiga66%Jardiance34%Part D≥27 patientsBlood & clotting
2.3%Factor Xa inhibitor2.3%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
11 NIH research awards on record, funded 2010–2025 per NIH RePORTER. The latest:
- Cardiovascular Risk Prediction and Reduction in Men with Prostate Cancer
University of Pennsylvania
FY2025$716,697R01HL182015 - MENTORING IN PATIENT-ORIENTED RESEARCH IN DEEP PHENOTYPING IN CARDIO-ONCOLOGY
University of Pennsylvania
FY2025$123,507K24HL167127 - Cardiovascular Risk Prediction and Reduction in Men with Prostate Cancer
University of Pennsylvania
FY2025$21,775R01HL182015
Congress activity
Updated 27 Aug 2026
36 congress contributions (2012–2025) across AACR, ASCO, ASH, ASTRO per OpenAlex. The most recent:
- Early cardiotoxicity and survival in pediatric Acute Myeloid Leukemia: The mediating roles of relapse and salvage chemotherapy intensity
ASH Annual Meeting
ASH2025Co-author - Abstract 6296: Biomarkers associated with atherosclerosis-related cardiovascular dysfunction in cancer survivors treated with anthracyclines
AACR Annual Meeting
AACR2024Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Cardiac remodelling and dysfunction in cancer patients receiving cardiotoxic therapies: proteomic and metabolomic profiling.
European heart journal
Article2026 - Chimeric antigen receptor T-cell therapy and cardiovascular outcomes in US Medicare beneficiaries.
European heart journal
Article2026 - Cardiovascular Adverse Events During Venetoclax-Based Treatment in Acute Myeloid Leukemia.
Journal of the American Heart Association
Article2026 - Cancer Treatment-Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration.
Cancer epidemiology, biomarkers & prevention
Article2026
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/bonnie-ky-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - X / Twitter
x.com/DrBonnieKy
Mentions by others
where others cite or feature them- Other
cardionerds.com/233-cardio-oncology-the-need-for-cardio-oncology-with-dr-bonnie-ky
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardionerds.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - X / Twitter
X/Twitter: @DrBonnieKy
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
Editorial & leadership roles
journal and society appointments- Editor-in-Chief
JACC: CardioOncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jacc.org ↗ - Trustee
American College of Cardiology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.upenn.edu ↗ - Director
Thalheimer Center for Cardio-Oncology, University of Pennsylvania
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →blog-ecog-acrin.org ↗
Secondary affiliations
appointments beyond the home institution- Faculty Member
Cardiovascular Institute, University of Pennsylvania School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗ - Faculty Member
Institute for Translational Medicine and Therapeutics, University of Pennsylvania
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗ - Member
Abramson Cancer Center, University of Pennsylvania
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardionerds.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancerhealth.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Carl June, MD
University of Pennsylvania
Harold Feldman, MD
University of Pennsylvania
Howard Herrmann, MD
University of Pennsylvania
Robert Vonderheide, MD
University of Pennsylvania